Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
about
Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.Structural changes and differentially expressed genes in Pseudomonas aeruginosa exposed to meropenem-ciprofloxacin combination.Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan.Activities of antibiotic combinations against resistant strains of Pseudomonas aeruginosa in a model of infected THP-1 monocytes.In vitro activities of linezolid combined with other antimicrobial agents against Staphylococci, Enterococci, Pneumococci, and selected gram-negative organisms.When does 2 plus 2 equal 5? A review of antimicrobial synergy testing.Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies.Comparative activity of trovafloxacin, alone and in combination with other agents, against gram-negative nonfermentative rodsOptimizing Polymyxin Combinations Against Resistant Gram-Negative BacteriaCurrent concepts in laboratory testing to guide antimicrobial therapyA novel combination approach of human polyclonal IVIG and antibiotics against multidrug-resistant Gram-positive bacteriaNovel approach to characterization of combined pharmacodynamic effects of antimicrobial agents.Novel Microdilution Method to Assess Double and Triple Antibiotic Combination Therapy In Vitro.Quantitative assessment of combination antimicrobial therapy against multidrug-resistant Acinetobacter baumannii.Synergy of drug combinations in treating multidrug-resistant Pseudomonas aeruginosa.In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.Activity of meropenem with and without ciprofloxacin and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.Activity of levofloxacin alone and in combination with a DnaK inhibitor against gram-negative rods, including levofloxacin-resistant strains.In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas aeruginosa.Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis.Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles.
P2860
Q33692980-263AC8F6-8229-4475-84B5-35BC92ACDAE0Q33798601-4BF7EE12-7684-480A-A136-2CB4142FE8F8Q33975978-2C2C03F4-3823-4C00-97A0-41371B98CEAEQ33983513-3ABDA625-0A68-4CFE-AA3D-7EF7B02A1EB6Q34141308-D0D21610-1497-42A9-B5B5-6DDC50E7490DQ34922363-F1F127FF-D8CE-4B7F-BE0F-E1F68980068EQ35014416-1998E533-D708-45A7-8F06-E7EC6E345662Q35036156-F2C06857-137D-47E3-B20A-964336A225F1Q35136059-171940CC-A4A4-4DA3-A842-0698D44EFFD2Q35137076-906EABE1-4E45-4A07-B92D-447B0DD4D643Q36363261-BAF24047-56A4-4F3E-9E0D-E2E70C079020Q36395704-0B888C62-F5CE-4001-81F4-9E1CCAC38260Q37496502-D60DACF1-21A4-4F45-A48C-F37B46D7B2EFQ40291140-7F7566DA-52B2-4C07-853F-CEA335DFF4B8Q40668393-9268A1E4-C75A-4821-88CE-800493CE817DQ41338910-C3F1ABC9-EF85-4DEF-8005-DC78E3BF9627Q41838771-BB3C3307-9AB7-4D23-BBC6-3FCC8B735F18Q41873335-786023F2-4DA4-4FF0-AA0F-7D6515F82574Q41912214-0E7DF503-D371-47C8-ADD7-065730E81173Q41949708-ADD5CEF1-E737-40CF-B5A2-99BB3B3DC6F3Q42016758-A9305EE0-525C-4A52-9D34-AB6A63A0C741Q42612276-0F4BEB79-2EEC-41FB-A17F-D8062D4C4496Q42722312-E7222759-FE3C-4850-94D7-77E9C3118A0C
P2860
Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@ast
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@en
type
label
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@ast
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@en
prefLabel
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@ast
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@en
P2860
P356
P1476
Comparison of methodologies fo ...... ains of Pseudomonas aeruginosa
@en
P2093
Cappelletty DM
P2860
P304
P356
10.1128/AAC.40.3.677
P407
P577
1996-03-01T00:00:00Z